Since the emergence of COVID-19, a great deal of research has been carried out to determine the structure of the virus and the mechanisms of infection and replication. Key points in the lifecycle have subsequently been identified as potential prophylactic or therapeutic targets. SARS-CoV-2 is a...
This week, we will shine a spotlight on how researchers are using a diverse set of computational, immunological, and single-cell tools to decipher the role of SARS-CoV-2 specific T cells. Could T cells be the key to defeating COVID-19? Bioinformatics Predict Targets for SARS-CoV-2-...
Since the beginning of the pandemic, we have played a significant role in addressing the devastating impact of COVID-19. The development, manufacture and supply of our COVID-19 vaccine was a principal achievement within our response to the COVID-19 pandemic. In partnership, we built over 25...
Leveraging COVID-19鈥揹edicated institutional and financial resources was also discussed. Finally, the disproportionate impact of COVID-19 on individuals of low socioeconomic status and minorities was highlighted as a key research area.doi:10.1002/ana.25784Eric C. Landsness...
COVID-19 has emerged as a widely researched topic and the academia has taken interest in the effects of COVID-19 in various sectors of human life and society. Most of the bibliometric research addresses scientific contributions in medicine, health, and virology related topics, with very little ...
This new Covid-19 belongs to the coronavirus family , which includes SARS (2003) and MERS-Cov (2012). The Covid-19 viral genome encodes several proteins with unique functions, including Spike protein, N protein and M protein. The two main proteins of pharmaceutical interest ...
As the COVID-19 pandemic shuts down labs across the globe, funders and institutions must step up to support scientists and ensure the healthy future of research. This is a preview of subscription content, access via your institution Relevant articles Open Access articles citing this article. ...
The pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the most formidable challenge to humanity in this century. The research and development of COVID-19 vaccines, which are believed to be the most ef...
OXON collaboration for the International programme 'RAPID' to evaluate non-randomised comparative studies of treatments for COVID-19.
Since the outbreak of novel coronavirus pneumonia (COVID-19) in December 2019, more than 2,500,000 people worldwide have been diagnosed with SARS-CoV-2 as of April 22. In response to this epidemic, China has issued seven trial versions of diagnosis and treatment protocol for COVID-19. Ac...